Skip to main content

Advertisement

Log in

Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Bone status impairment represents a complication of generalized forms of epidermolysis bullosa (EB); however, the prevalence and the main determinants of this event in localized forms remain poorly defined. Birmingham epidermolysis bullosa severity (BEBS) score and 25-hydroxyvitamin D levels are strongly associated with low bone mass, suggesting that vitamin D may play a potential beneficial role in bone health. Further longitudinal studies are needed in order to confirm this hypothesis.

Introduction

Bone status impairment represents a complication of generalized forms of EB; thus, we aimed to estimate the prevalence of low bone mass, to examine mineralization differences in various EB subtypes and to identify the most important determinants of bone impairment in children with either generalized or localized EB.

Methods

An observational study of 20 children (11 males; mean age ± standard deviation, 11.7 ± 3.9 years) with EB was performed. Clinical history, physical examination, laboratory studies, X-ray of the left hand and wrist for bone age, and dual energy X-ray absorptiometry scans of the lumbar spine were obtained. Areal bone mineral density (aBMD Z-scores) and bone mineral apparent density were related to the BEBS score.

Results

Areal BMD Z-score (mean −1.82 ± 2.33, range, −7.6-1.7) was reduced (<−2 SD) in 8 patients (40%), whereas aBMD Z-score adjusted for bone age was low in 7 patients (35%). BEBS score and 25-hydroxyvitamin D serum levels were the most important elements associated with aBMD (P = 0.0001 and P = 0.016, respectively). A significant correlation between the aBMD Z-score and area of skin damage, insulin-like growth factor-1, C-reactive protein, and sodium serum levels was also found.

Conclusions

Low aBMD can be considered a systemic complication of EB, primarily associated with BEBS score and 25-hydroxyvitamin D levels. Therefore, longitudinal evaluation of bone status is ongoing in these patients to define whether vitamin D supplementation would prevent, or at least reduce, bone status impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Fine JD (2010) Inherited epidermolysis bullosa: recent basic and clinical advances. Curr Opin Pediatr 22:453–458

    Article  PubMed  Google Scholar 

  2. Tadini G, Gualandri L, Colombi M, Paradisi M, Angelo C, Zambruno G et al (2005) The Italian registry of hereditary epidermolysis bullosa. G Ital Dermatol Venereol 140:359–372

    Google Scholar 

  3. Intong LR, Murrell DF (2012) Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 30:70–77

    Article  PubMed  Google Scholar 

  4. Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C et al (2014) Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 70:1103–1126

    Article  PubMed  Google Scholar 

  5. Fine JD, Mellerio JE (2009) Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 61:367–384

    Article  PubMed  Google Scholar 

  6. Fine JD, Mellerio JE (2009) Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 61:387–402

    Article  PubMed  Google Scholar 

  7. Bachrach LK (2001) Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22–28

    Article  CAS  PubMed  Google Scholar 

  8. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  CAS  PubMed  Google Scholar 

  9. Annicchiarico G, Morgese MG, Esposito S, Lopalco G, Lattarulo M, Tampoia M et al (2015) Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa. Medicine (Baltimore) 94:e1528

    Article  CAS  Google Scholar 

  10. Reyes ML, Cattani A, Gajardo H, Garcia C, McGrath JA, Palisson F (2002) Bone metabolism in children with epidermolysis bullosa. J Pediatr 140:467–469

    Article  PubMed  Google Scholar 

  11. Fewtrell MS, Allgrove J, Gordon I, Brain C, Atherton D, Harper J et al (2006) Bone mineralization in children with epidermolysis bullosa. Br J Dermatol 154:959–962

    Article  CAS  PubMed  Google Scholar 

  12. Bruckner L, Bedocs LA, Keiser E, Tang JY, Doernbrack C, Arbuckle HA et al (2011) Correlates of low bone mass in children with generalized forms of epidermolysis bullosa. J Am Acad Dermatol 65:1001–1009

    Article  PubMed  Google Scholar 

  13. Fu T, Lingala B, Kent K, Bachrach LK, Bruckner AL (2011) Pattern of bone mineral acquisition in children with epidermolysis bullosa: a longitudinal study. Br J Dermatol 165:1081–1086

    Article  CAS  PubMed  Google Scholar 

  14. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A et al (2008) The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on diagnosis and classification of EB. J Am Acad Dermatol 58:931–950

    Article  PubMed  Google Scholar 

  15. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R et al (2000) CDC growth charts: United States. Adv Data 314:1–27

    Google Scholar 

  16. Greulich WW, Pyle SL (1959) Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford University Press, Stanford

    Google Scholar 

  17. Marshall WA, Tanner JM (1970) Variation in pattern of pubertal changes in boys. Arch Dis Child 45:13–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Marshall WA, Tanner JM (1969) Variation in pattern of pubertal changes in girls. Arch Dis Child 44:291–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Moss C, Wong A, Davies P (2009) The Birmingham epidermolysis bullosa severity score: development and validation. Br J Dermatol 160:1057–1065

    Article  CAS  PubMed  Google Scholar 

  20. Montomoli M, Gonnelli S, Ghiacchi M, Mattei R, Cuda C, Rossi S et al (2002) Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr 56:21–30

    Article  CAS  PubMed  Google Scholar 

  21. Institute of Medicine (IOM) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, pp. 260–262

    Google Scholar 

  22. Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S et al (2010) Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265–1273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bianchi ML (2007) Osteoporosis in children and adolescents. Bone 41:486–495

    Article  PubMed  Google Scholar 

  24. Official Pediatric Position of the ISCD. Skeletal Health Assessment In Children from Infancy to Adolescence, 2013

  25. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F et al (2007) Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13:416–423

    Article  PubMed  Google Scholar 

  26. Esposito S, Guez S, Manzoni F, Bosco A, Rigante D (2015) Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate? Immunol Res 61:63–69

    Article  CAS  PubMed  Google Scholar 

  27. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D et al (2013) Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98:1283–1304

    Article  Google Scholar 

  28. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008) Drug and Therapeutics Committee of the Lawson Wilkins, Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122:398–417

    Article  PubMed  Google Scholar 

  29. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2012) Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97:1153–1158

    Article  CAS  PubMed  Google Scholar 

  30. Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P et al (2013) Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. Eur J Pediatr 172:1607–1617

    Article  CAS  PubMed  Google Scholar 

  31. Marchisio P, Consonni D, Baggi E, Zampiero A, Bianchini S, Terranova L et al (2013) Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J 32:1055–1060

    Article  PubMed  Google Scholar 

  32. Marzano AV, Trevisan V, Eller-Vainicher C, Cairoli E, Marchese L, Morelli V et al (2012) Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases. Br J Dermatol 167:688–691

    Article  CAS  PubMed  Google Scholar 

  33. Marzano AV, Trevisan V, Cairoli E, Eller-Vainicher C, Morelli V et al (2015) Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study. Orphanet J Rare Dis 10:8

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M et al (2015) The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship of bone mineral density with prevalent vertebral fractures. J Clin Endocrinol Metab 100:1018–1127

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Giavoli.

Ethics declarations

We performed this observational study at the Center for Epidermolysis in Northern Italy at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan. The study was approved by the Ethics Committee of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico. Parental written informed consent was obtained from parents before enrolment; moreover, children ≥8 years were required to give their written assent before entering the study.

Conflicts of interest

None.

Additional information

This work was supported by Ricerca Corrente Funds of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodari, G., Guez, S., Manzoni, F. et al. Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa. Osteoporos Int 28, 1385–1392 (2017). https://doi.org/10.1007/s00198-016-3883-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3883-1

Keywords

Navigation